Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Bryan

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
BMC Medicine|December 3, 2025
Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancerYa-Ting Chen, Jing Sui, Yu Yang, et al.
European Urology Oncology|August 6, 2021
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder CancerTessel E Galesloot, Anne J Grotenhuis, Dimitar Kolev, et al.
Cancer Genetics|June 19, 2026
Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancerJasper P Hof, Tessel E Galesloot, Katja K H Aben, et al.
BJU International|May 12, 2019
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratificationDouglas G Ward, Naheema S Gordon, Rebecca H Boucher, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 17, 2021
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient ExperienceAgustina Bessa, Cecilia Bosco, Fidelma Cahill, et al.
International Journal of Cancer|April 15, 2020
Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants StudySylvia H J Jochems, Raoul C Reulen, Frits H M van Osch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath TrialRichard T Bryan, Wenyu Liu, Sarah J Pirrie, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
BMC Medicine|December 3, 2025
Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancerYa-Ting Chen, Jing Sui, Yu Yang, et al.
European Urology Oncology|August 6, 2021
Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder CancerTessel E Galesloot, Anne J Grotenhuis, Dimitar Kolev, et al.
Cancer Genetics|June 19, 2026
Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancerJasper P Hof, Tessel E Galesloot, Katja K H Aben, et al.
BJU International|May 12, 2019
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratificationDouglas G Ward, Naheema S Gordon, Rebecca H Boucher, et al.
Lancet (London, England)|March 9, 2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialAlison Birtle, Mark Johnson, John Chester, et al.
Clinical Epigenetics|February 7, 2017
UroMark-a urinary biomarker assay for the detection of bladder cancerAndrew Feber, Pawan Dhami, Liqin Dong, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 17, 2021
Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient ExperienceAgustina Bessa, Cecilia Bosco, Fidelma Cahill, et al.
International Journal of Cancer|April 15, 2020
Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants StudySylvia H J Jochems, Raoul C Reulen, Frits H M van Osch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath TrialRichard T Bryan, Wenyu Liu, Sarah J Pirrie, et al.
Pageof 14